Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.4581 per EA under NDC 67877054360. Its NADAC has been published 264 times since Jun 9, 2021.
Strength
300 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877054360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA210220On Market Since
2/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 264 times since Jun 9, 2021, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4581 per EA |
|---|---|
| All-time high | $0.5647 (Aug 11, 2021) |
| All-time low | $0.3507 (Nov 20, 2024) |
| 52-week high | $0.4752 |
| 52-week low | $0.4551 |
| Median price | $0.4676 |
| Average price | $0.4659 |
| Largest weekly change | -25.5% (Nov 20, 2024) |
| Weeks tracked | 264 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.4581 per EA (NDC 67877054360), effective Jun 24, 2026.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 5.1%. It has been tracked across 264 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Jun 9, 2021, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.3507 (Nov 20, 2024) to a high of $0.5647 (Aug 11, 2021), with a median of $0.4676 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as CEFDINIR 300 MG CAPSULE, but none are currently priced below it.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 67877054360) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification